3 results  1 of 1 

1 Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
Masaya Uno, Rie Matsuo, Naoki Maezawa, Tomoyasu Kato
Obstet Gynecol Sci.2023;66(4):290-299.   Published online 2023 July 15     DOI: http://dx.doi.org/10.5468/ogs.23024
      
2 The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4
Kyung Hee Han, Noh Hyun Park, Jin Ju Kim, Sunmie Kim, Hee Seung Kim, Maria Lee, Yong Sang Song
J Gynecol Oncol.2019;30(6):e83.  Published online 2019 May 20     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e83
      
3 Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study
Shin Hye Chung, Soo Yoon Lee, Woong Ju, Seung Cheol Kim
Obstet Gynecol Sci.2013;56(4):234-241.   Published online 2013 July 15     DOI: http://dx.doi.org/10.5468/ogs.2013.56.4.234
      

 1 of 1